CHRONIC MYELOID LEUKEMIA
Clinical trials for CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame leukemia without lifelong pills?
Disease control Not yet recruitingThis study tests whether combining dasatinib and ropeginterferon can better control chronic myeloid leukemia in its early phase. About 40 adults with newly diagnosed CML will receive the drug combo, and researchers will monitor side effects and how well the disease responds. The …
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Exercise-Powered immune cells take on leukemia in first human trial
Disease control Not yet recruitingThis early-stage study tests whether donor immune cells collected after exercise can better prevent or treat leukemia relapse in patients who had a stem cell transplant. About 94 participants with various blood cancers will receive these special cells either to prevent relapse or…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
CML drugs may change your metabolism – new study investigates
Knowledge-focused Not yet recruitingThis study will check how tyrosine kinase inhibitors (TKIs), the main drugs for chronic myeloid leukemia (CML), affect blood sugar and cholesterol levels. Researchers will measure changes in HbA1c (a blood sugar marker) and lipid profile (cholesterol and fats) in 75 CML patients.…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC